Liver Scan: A Safer and More Advanced Approach

     With advancements in modern medicine, liver health assessments have become more precise with the introduction of the Liver Scan. This device, resembling an ultrasound machine, serves as a non-invasive alternative to liver biopsy. It enables the simultaneous measurement of fat accumulation and fibrosis in the liver without the risks associated with biopsy procedures, making the examination both safer and painless.

Who Should Undergo a Liver Health Screening?

Liver health screening is recommended for:

• Patients with chronic liver inflammation, such as those with hepatitis B or hepatitis C.
• Individuals diagnosed with fatty liver disease, who should undergo further evaluation to assess the presence of fibrosis.
• Those at risk of developing fatty liver disease without their knowledge, including individuals with diabetes, obesity, or abdominal obesity.
• Individuals who regularly consume alcohol.

Fatty Liver Disease: A Common Liver Condition

     Fatty liver disease is frequently detected through liver examinations. In its early stages, fibrosis may begin to develop, or, in some cases, the condition may progress to early-stage cirrhosis. Patients in these stages often experience no noticeable symptoms. The disease may take 5 to 10 years to advance to symptomatic cirrhosis, at which point liver function is significantly impaired.

Symptoms of Liver Cirrhosis

As liver cirrhosis progresses, the following symptoms may occur:

• Abdominal swelling due to fluid accumulation.
• Jaundice, characterized by yellowing of the skin.
• Yellowing of the eyes.
• Vomiting blood, which can be an indication of severe liver damage or even liver cancer.

Patients who develop symptoms of liver cirrhosis have a high mortality risk within the first 1–2 years.

Early Detection for Timely Intervention

     Would it not be better to identify at-risk individuals at an early stage? Early detection allows for appropriate treatment and helps slow or prevent disease progression to advanced cirrhosis or severe liver cancer. Prioritizing timely screening can significantly improve long-term health outcomes.